Significant CD5 expression on normal stage 3 hematogones and mature B lymphocytes in bone marrow

Franklin S. Fuda, Nitin J. Karandikar, Weina Chen

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

B-cell maturation from hematogones to mature B cells in bone marrow exhibits a consistent, complex spectrum of sequential antigen expression. CD5 expression, however, has not been characterized. We studied the dynamics of CD5 expression on developing B cells by 4-color flow cytometry in 32 patients, aged 9 months to 63 years, with hematogone hyperplasia (>3.5% of total events). The mean percentage of hematogones was 8.1%. We demonstrate consistent CD5 expression on normal, polytypic B cells in a continuum, predominantly at later stages of maturation, specifically on stage 3 hematogones and mature B cells. Awareness of this normal pattern of CD5 expression on B-cell subsets has implications in the analysis of minimal residual disease of CD5+ B-lineage non-Hodgkin lymphomas.

Original languageEnglish (US)
Pages (from-to)733-737
Number of pages5
JournalAmerican Journal of Clinical Pathology
Volume132
Issue number5
DOIs
StatePublished - 2009

Fingerprint

B-Lymphocytes
Bone Marrow
B-Lymphocyte Subsets
Residual Neoplasm
Non-Hodgkin's Lymphoma
Hyperplasia
Flow Cytometry
Color
Antigens

Keywords

  • CD5
  • Hematogones
  • Mature B cells
  • Multiparameter flow cytometry

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Significant CD5 expression on normal stage 3 hematogones and mature B lymphocytes in bone marrow. / Fuda, Franklin S.; Karandikar, Nitin J.; Chen, Weina.

In: American Journal of Clinical Pathology, Vol. 132, No. 5, 2009, p. 733-737.

Research output: Contribution to journalArticle

@article{997289ca84b142fda74afcea2eb25e33,
title = "Significant CD5 expression on normal stage 3 hematogones and mature B lymphocytes in bone marrow",
abstract = "B-cell maturation from hematogones to mature B cells in bone marrow exhibits a consistent, complex spectrum of sequential antigen expression. CD5 expression, however, has not been characterized. We studied the dynamics of CD5 expression on developing B cells by 4-color flow cytometry in 32 patients, aged 9 months to 63 years, with hematogone hyperplasia (>3.5{\%} of total events). The mean percentage of hematogones was 8.1{\%}. We demonstrate consistent CD5 expression on normal, polytypic B cells in a continuum, predominantly at later stages of maturation, specifically on stage 3 hematogones and mature B cells. Awareness of this normal pattern of CD5 expression on B-cell subsets has implications in the analysis of minimal residual disease of CD5+ B-lineage non-Hodgkin lymphomas.",
keywords = "CD5, Hematogones, Mature B cells, Multiparameter flow cytometry",
author = "Fuda, {Franklin S.} and Karandikar, {Nitin J.} and Weina Chen",
year = "2009",
doi = "10.1309/AJCPU5E3NXEKLFIY",
language = "English (US)",
volume = "132",
pages = "733--737",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "5",

}

TY - JOUR

T1 - Significant CD5 expression on normal stage 3 hematogones and mature B lymphocytes in bone marrow

AU - Fuda, Franklin S.

AU - Karandikar, Nitin J.

AU - Chen, Weina

PY - 2009

Y1 - 2009

N2 - B-cell maturation from hematogones to mature B cells in bone marrow exhibits a consistent, complex spectrum of sequential antigen expression. CD5 expression, however, has not been characterized. We studied the dynamics of CD5 expression on developing B cells by 4-color flow cytometry in 32 patients, aged 9 months to 63 years, with hematogone hyperplasia (>3.5% of total events). The mean percentage of hematogones was 8.1%. We demonstrate consistent CD5 expression on normal, polytypic B cells in a continuum, predominantly at later stages of maturation, specifically on stage 3 hematogones and mature B cells. Awareness of this normal pattern of CD5 expression on B-cell subsets has implications in the analysis of minimal residual disease of CD5+ B-lineage non-Hodgkin lymphomas.

AB - B-cell maturation from hematogones to mature B cells in bone marrow exhibits a consistent, complex spectrum of sequential antigen expression. CD5 expression, however, has not been characterized. We studied the dynamics of CD5 expression on developing B cells by 4-color flow cytometry in 32 patients, aged 9 months to 63 years, with hematogone hyperplasia (>3.5% of total events). The mean percentage of hematogones was 8.1%. We demonstrate consistent CD5 expression on normal, polytypic B cells in a continuum, predominantly at later stages of maturation, specifically on stage 3 hematogones and mature B cells. Awareness of this normal pattern of CD5 expression on B-cell subsets has implications in the analysis of minimal residual disease of CD5+ B-lineage non-Hodgkin lymphomas.

KW - CD5

KW - Hematogones

KW - Mature B cells

KW - Multiparameter flow cytometry

UR - http://www.scopus.com/inward/record.url?scp=70449726998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449726998&partnerID=8YFLogxK

U2 - 10.1309/AJCPU5E3NXEKLFIY

DO - 10.1309/AJCPU5E3NXEKLFIY

M3 - Article

C2 - 19846815

AN - SCOPUS:70449726998

VL - 132

SP - 733

EP - 737

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 5

ER -